Companlunguard Is Developing A Novel Technology Solution For Thefutureof Critical Caremedicineicuthat Enables Better Nutritiontreatment And Reducing Nosocomial Infection In Theicuthenew Approach Of Thepersonalized Physiological Medicineppm Based On A Smart Peristaltic Enteral Feeding Tubethat Is Structured From Several Inflatableballoons Used As A Multi Sensory Platformlunguard S Innovativesolutiontogether With Thesubstantial Clinical Needis Designed To Safely Block Gastro Esophageal Refluxgerand Reducenosocomial Infection In Theicu That Causeventilator Associated Pneumoniavap Vap Leads To Liferisking Clinical Complications That Areunrelated To Theinitial Reason Of Hospitalizationclinical Complications Requirecomplex Medical Treatmentdeterioratepatient Conditions And Prolong Thepatient S Length Of Staylos Thelunguard Technology Brings Theoptimal Platform For Futurepersonalized Medicineby Capturing Critical Data From Different Physiological Locations Egsealing Mechanism Within Theesophagus And Transpulmonary Pressuretppfrom Therespiratory Airwayin Additionthesystem Monitors Thedysmotility Of Theupper Gastrointestinalgibased On Theesophageal And Stomach Contractions Fluctuationph Impedancesensors Will Monitor Theinfection Prevention Effectiveness And Beableto Proposean Accelerated Feeding Protocol From All Aspects Ae Optimal Recovery Of Thepatient With Minimum Exposureto Gastric Aspiration Infectionthesystemwith Its Sophisticated Ai Algorithmwill Demonstratein A Real Timebetter Infection Preventionoptimal Feeding And Optimal Ventilation
